12.30
Wave Life Sciences Ltd Aktie (WVE) Neueste Nachrichten
Jefferies reiterates Buy on Wave Life Sciences stock ahead of May data - Investing.com
Guidance Update: Can Wave Life Sciences Ltd beat the S P 5002026 AllTime Highs & Expert Verified Movement Alerts - baoquankhu1.vn
WVE: Mizuho Maintains Outperform, Raises Price Target to $27 | W - GuruFocus
WAVE Life Sciences (NASDAQ:WVE) Price Target Raised to $27.00 at Mizuho - MarketBeat
Here’s What Boosted Wave Life Sciences Ltd. (WVE) in Q4 - Insider Monkey
Mizuho raises Wave Life Sciences stock price target on obesity drug progress - Investing.com UK
Avoiding Lag: Real-Time Signals in (WVE) Movement - Stock Traders Daily
Traders Purchase Large Volume of WAVE Life Sciences Put Options (NASDAQ:WVE) - MarketBeat
Wave Life Sciences Hits Day Low of $13.59 Amid Price Pressure - Markets Mojo
Wave Life Sciences Ltd. (NASDAQ:WVE) Q4 2025 earnings call transcript - MSN
Quarterly Trades: Does Wave Life Sciences Ltd stock have upside surprise potential2026 Macro Moves & Weekly Return Optimization Plans - baoquankhu1.vn
WVE Stock Price, Quote & Chart | WAVE LIFE SCIENCES LTD (NASDAQ:WVE) - ChartMill
Wave Life Sciences reports positive early data from obesity drug trial - MSN
WVE Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
WAVE Life Sciences teams prepare to share development insights at OPTBoston - Traders Union
BofA highlights WVE-007 as primary driver for Wave Life Sciences Ltd. (WVE)’s growth, projecting peak sales above $11B - MSN
Cinctive Capital Management LP Lowers Holdings in WAVE Life Sciences Ltd. $WVE - MarketBeat
Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE), Wave Life Sciences (WVE) and Telix Pharmaceuticals (OtherTLPPF) - The Globe and Mail
Assessing Wave Life Sciences (WVE) Valuation After WVE-007 Obesity Data And Cash Runway Update - simplywall.st
WAVE Life Sciences Ltd. (NASDAQ:WVE) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Discipline and Rules-Based Execution in WVE Response - Stock Traders Daily
Dynamic SXSW panel reshapes obesity treatment narrative, WAVE Life Sciences asserts - Traders Union
Canaccord Genuity Boosts Price Target for WAVE Life Sciences (WV - GuruFocus
WAVE Life Sciences Stock: A Deep Dive Into Analyst Perspectives (11 Ratings) - Benzinga
WAVE Life Sciences (NASDAQ:WVE) Given New $52.00 Price Target at Canaccord Genuity Group - MarketBeat
Wave Life Sciences (WVE) soars to 6-year high on obesity drug clinical trial - MSN
Wave Life Sciences to present WVE-006 trial data at ATS - Investing.com Nigeria
Wave Life Sciences (WVE) Is Down 5.8% After Wider Losses And WVE-006 Accelerated Approval PushWhat's Changed - simplywall.st
Wave Life Sciences Bets on Data Over Near-Term Revenue - TipRanks
WVE: Wedbush Raises Price Target for WAVE Life Sciences, Reaffir - GuruFocus
Wave Life Sciences (WVE) Valuation Check After New RNA Editing And Obesity Trial Updates - simplywall.st
Wedbush Forecasts Strong Price Appreciation for WAVE Life Sciences (NASDAQ:WVE) Stock - MarketBeat
Wave Life Sciences (WVE) Anticipates Positive Developments with WVE-007 Data - GuruFocus
Wave Life Sciences Announces Acceptance of Late-Breaking Oral Presentation on WVE-006 for Alpha-1 Antitrypsin Deficiency at the American Thoracic Society International Conference - Sahm
Wave Life Sciences to present WVE-006 trial data at ATS By Investing.com - Investing.com Canada
Wave Life Sciences announces acceptance of late-breaking oral presentation on Wve-006 for alpha-1 antitrypsin deficiency at the American Thoracic Society international conference - marketscreener.com
Wave Life Sciences Announces Acceptance of Late-Breaking - GlobeNewswire
Q1 EPS Forecast for WAVE Life Sciences Raised by Analyst - MarketBeat
Experimental RNA treatment for alpha-1 gets late-breaking lung conference slot - Stock Titan
FY2029 Earnings Forecast for WVE Issued By HC Wainwright - MarketBeat
Wave Life Sciences Obesity Proof Of Concept Sparks Focus On Pipeline Upside - simplywall.st
WVE SEC FilingsWave Life Scienc 10-K, 10-Q, 8-K Forms - Stock Titan
Wave Life Sciences Ltd. (WVE) Stock Analysis: Biotechnology Innovator with 140% Upside Potential - DirectorsTalk Interviews
How Strong Q4 Revenue Amid Deeper Losses At Wave Life Sciences (WVE) Has Changed Its Investment Story - Yahoo Finance
Wave Life Sciences (WVE) Earnings Call Transcript - AOL.com
Wave Life Sciences Ltd. (NASDAQ:WVE) Q4 2025 Earnings Call Transcript - Insider Monkey
HC Wainwright Reiterates "Buy" Rating for WAVE Life Sciences (NASDAQ:WVE) - MarketBeat
Wave Life Sciences Teases Near-Term Obesity and RNA Editing Data as INLIGHT Readouts Near - Yahoo Finance
Artisan Partners Limited Partnership Trims Stake in WAVE Life Sciences Ltd. $WVE - MarketBeat
How Mixed Q4 Results, Obesity Data and Cash Runway News At Wave Life Sciences (WVE) Has Changed Its Investment Story - simplywall.st
Wave Life Sciences Ltd. (WVE): A Bull Case Theory - Finviz
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):